|
May 1
|
These Stocks Are Moving the Most Today: First Republic, JPMorgan, Iveric Bio, SoFi, ON Semi, and More
|
|
May 1
|
Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas Pharma
|
|
May 1
|
Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration'
|
|
May 1
|
Iveric Bio Agrees to $5.9 Billion Bid From Astellas. Buyers Are Hunting Biopharma Bargains.
|
|
May 1
|
Japan’s Astellas to buy US biotech group Iveric Bio for $5.9bn
|
|
Apr 30
|
UPDATE 1-Japan's Astellas Pharma agrees to buy IVERIC Bio for $5.9 bln
|
|
Apr 30
|
Japan's Astellas to buy Iveric Bio for $5.9 billion to expand eyesight treatments
|
|
Apr 30
|
Astellas Enters into Definitive Agreement to Acquire Iveric Bio
|
|
Apr 25
|
When Will IVERIC bio, Inc. (NASDAQ:ISEE) Breakeven?
|